Significant efforts have been made in the last decade to develop evidence-based guidelines
for the treatment of insomnia and other sleep disorders. Despite such progress, there are still …

Introduction: The purpose of this guideline is to establish clinical practice recommendations
for the pharmacologic treatment of chronic insomnia in adults, when such treatment is …

For many years practitioners have had limited data from double-blind, placebo-controlled
studies to guide the types of decision-making needed to optimally manage patients with …

This paper reviews the evidence regarding the efficacy of nonpharmacological treatments
for primary chronic insomnia. It is based on a review of 48 clinical trials and two meta …

Several different types of medications are currently available for the treatment of insomnia.
These agents include:(1) a group approved by the US Food and Drug Administration (FDA) …

Background Pharmacological treatment is common in practice and widely used for the
management of insomnia. However, evidence comparing the relative effectiveness, safety …

Abstract Study Objectives: To present expert consensus recommendations for a standard set
of research assessments in insomnia, reporting standards for these assessments, and …

Insomnia is believed to have high prevalence, cost, and impact. However, comprehensive
cost-effectiveness analyses (CEAs) of different diagnostic and treatment strategies have not …

Objective Insomnia is a common sleep disorder. There are many clinical-intervention
methods for treating this condition, but thus far, the most effective method has not been …

Chronic insomnia is the most common sleep disorder among adults and is associated with a
wide range of negative outcomes. This article reviews the economic consequences of the …